Skip to main content

NASDAQ:CLSD Stock Forecast, Price Targets (Buy or Sell) | CLSD Clearside Biomedical Analyst Ratings



In this scenario, we would still include the existing debt maturity as a use of liquidity in our A/B and A-B calculations, if the debt matures within the corresponding liquidity horizon. The rationale is that our liquidity assessment is essentially a stress test against a sudden and severe loss of capital markets access availability. For companies with an anchor of at least 'bbb-' that meet certain characteristics, as outlined in paragraphs 38 and 39 of the criteria, we may use a shorter three- to six-month time horizon when assessing upcoming maturities.

We estimate CLSD Clearside Biomedical stock forecast parameters by: Commodity Channel Index with Polynomial Regression



CLSD Clearside Biomedical Stock Forecast (Buy or Sell) as of 14 May 2022 for (n+7)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Commodity Channel Index and Polynomial Regression. Machine Learning based stock forecast (n+7) for CLSD Clearside Biomedical as below:

Time series to forecast n: 14 May 2022 for (n+7)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |